{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:29:09Z","timestamp":1761514149748,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jcjd.2018.01.011","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T12:58:23Z","timestamp":1517835503000},"page":"205-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience"],"prefix":"10.1016","volume":"42","author":[{"given":"Benoit","family":"Imbeault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2018.01.011_bib0010","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0015","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/eurheartj\/ehr379","article-title":"Beyond salt: Lifestyle modifications and blood pressure","volume":"32","author":"Frisoli","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-144-7-200604040-00007","article-title":"Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial","volume":"144","author":"Elmer","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes","volume":"317","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0040","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s001250050629","article-title":"Appropriate blood pressure control in NIDDM (ABCD) trial","volume":"39","author":"Schrier","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0045","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0050","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0060","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0065","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.clinthera.2007.05.010","article-title":"Hypertension treatment in a medicare population: Adherence and systolic blood pressure control","volume":"29","author":"Fung","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0075","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0025","first-page":"569","article-title":"Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0080","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension","volume":"33","author":"Thomopoulos","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0090","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.111.177592","article-title":"Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice","volume":"58","author":"Corrao","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.112.201566","article-title":"Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: A matched cohort study","volume":"61","author":"Gradman","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/HYPERTENSIONAHA.110.159939","article-title":"Efficacy and duration of benazepril plus amlodipine or hydrochlorthiazide on 24-hour ambulatory systolic blood pressure control","volume":"57","author":"Jamerson","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0110","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","article-title":"Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure","volume":"47","author":"Ernst","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0120","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results","volume":"248","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: Meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0130","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","article-title":"Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: A meta-analysis","volume":"55","author":"Gupta","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0140","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/HYPERTENSIONAHA.108.123455","article-title":"A simplified approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial","volume":"53","author":"Feldman","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/jcpt.12185","article-title":"A multifaceted pharmacist intervention to improve antihypertensive adherence: A cluster-randomized, controlled trial (HAPPy trial)","volume":"39","author":"Stewart","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archinternmed.2011.1307","article-title":"A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans","volume":"172","author":"Ogedegbe","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0155","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: Its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","author":"Morisky","year":"2008","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1527-5299.2003.03269.x","article-title":"Adherence to antihypertensive therapy with fixed-dose amlodipine besylate\/benazepril HCl versus comparable component-based therapy adhering","volume":"9","author":"Taylor","year":"2003","journal-title":"Congest Heart Fail"},{"year":"2013","series-title":"Accelerating progress in prescription medicine adherence: The adherence action agenda","author":"National Council on Patient Information Education","key":"10.1016\/j.jcjd.2018.01.011_bib0170"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ajhp\/60.7.657","article-title":"Meta-analysis of trials of interventions to improve medication adherence","volume":"60","author":"Peterson","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.jcjd.2018.01.011_bib0180","article-title":"Interventions for enhancing medication adherence","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF02850081","article-title":"Medication adherence and persistence: A comprehensive review","volume":"22","author":"Krueger","year":"2005","journal-title":"Adv Ther"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0190","first-page":"41","article-title":"Effect of initial drug choice on persistence with antihypertensive therapy: The importance of actual practice data","volume":"160","author":"Caro","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0195","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/HJH.0b013e328339f9fa","article-title":"Reduced discontinuation of antihypertensive treatment by two-drug combination as first step: Evidence from daily life practice","volume":"28","author":"Corrao","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0200","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1751-7176.2011.00550.x","article-title":"Single-pill vs free-equivalent combination therapies for hypertension: A meta-analysis of health care costs and adherence","volume":"13","author":"Sherrill","year":"2011","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0205","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1185\/03007995.2010.534129","article-title":"Adherence and persistence of single-pill ARB\/CCB combination therapy compared to multiple-pill ARB\/CCB regimens","volume":"26","author":"Zeng","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0210","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1185\/03007995.2010.494462","article-title":"Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives","volume":"26","author":"Yang","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jcjd.2018.01.011_bib0030","first-page":"557","article-title":"Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults","volume":"33","author":"Leung","year":"2017","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267117307815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267117307815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:31:56Z","timestamp":1761492716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267117307815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1499267117307815"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2018.01.011","relation":{},"ISSN":["1499-2671"],"issn-type":[{"type":"print","value":"1499-2671"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2018.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}